Andreas Frank joins Dentsply Sirona’s Executive Leadership Team as Executive Vice President Product Group

Dentsply Sirona
Andreas frank

0 Shares

Andreas Frank recently joined Dentsply Sirona as Executive Vice President Product Group and member of the Executive Leadership Team, as well as Co-Chair of the company’s DE&I Council. In this role, he assumes responsibility for the Consumables, Implants, Clear Aligners, and Wellspect businesses, as well as the Corporate Development and Strategy function of Dentsply Sirona. The respective Leaders directly report to him. Andreas Frank reports to CEO Simon Campion.

Andreas frank

Andreas Frank sits down with our editor-in-chief, Dr. Paul Feuerstein, during DS World 2022

“I am very pleased that a professional of the caliber of Andreas Frank has joined the Dentsply Sirona team,” said Simon Campion, CEO of Dentsply Sirona. “Andreas is a seasoned executive with over 20 years of healthcare experience and a broad background in driving business and portfolio growth, developing talent and strategic deployment and execution. I am convinced that under Andreas’ leadership and with the support of the teams, we will begin the realization of our full potential.”

“Being able to connect with customers, partners, industry experts and employees at Dentsply Sirona World in Las Vegas was really inspiring,” said Andreas Frank. “It is truly the ‘Ultimate Experience in Digital Dentistry’. Combining market-leading clinical education and networking, this event also serves as a window into the future. I look forward to continuing to transform dentistry and advance oral health together with Dentsply Sirona!”

Andreas frank

Our editor-in-chief, Dr. Paul Feuerstein, talks to Andreas Frank at DS World 2022.

Andreas Frank joined Dentsply Sirona most recently from his position as President Front Line Care at Baxter. Prior to that he spent 10 years as a Member of the Executive Leadership Team at Hillrom, where he served as Senior Vice President and President Front Line Care for several years prior to the acquisition by Baxter. His prior responsibilities include Senior Vice President Corporate Development & Strategy and Chief Transformation Officer at Hillrom, managing all aspects of strategy development and execution, M&A and market research.

Before that, he served first as Vice President Business Development and subsequently as Director Corporate Development at Danaher Corporation, focused on building out the dental platform and investments across the Danaher portfolio. He also worked at McKinsey & Company earlier in his career.

Andreas holds a German Master’s Degree in Economics and Business Administration, awarded by the Otto Beisheim School of Management in Koblenz (Germany), and an MBA from the University of Texas in Austin, McCombs School of Business.


About Dentsply Sirona

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands.

Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarter is located in Charlotte, North Carolina. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY.

Visit dentsplysirona.com for more information about Dentsply Sirona and its products.


DISCLAIMER

This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference.

You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast”, and similar words and expressions. However, these words are not the exclusive means of identifying such statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share and other measures of results of operations and the prospects of future growth of our business.

These forward-looking statements are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict.

For a discussion of such risks, uncertainties and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.

buy ivermectin where to buy ivermectin for humans
where to buy viagra where can i buy viagra
cialis online buy cialis online